Clin2
NCT07403071Likely a fitNot yet recruiting

Fish oil to prevent nerve damage from bortezomib in multiple myeloma

Multiple MyelomaPeripheral Neuropathy Due to Chemotherapy

Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.

This trial tests if taking fish oil can help prevent nerve pain and numbness caused by the chemotherapy drug bortezomib in people with multiple myeloma. It combines data analysis, lab work, and a clinical study to find out.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have multiple myeloma and your doctor plans to start you on bortezomib as your first treatment.
  • You do not already have nerve pain or numbness in your hands or feet.
  • You are able to take medication as directed.
  • If you could become pregnant, your pregnancy test is negative and you are not breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07423390Recruiting· Phase 3
Vitamin B12 to prevent nerve damage from chemo

This trial tests if taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve pain and numbness caused by taxane chemotherapy. It may help people getting chemo for several types of cancer.

Xining, Qinghai
NCT07226609Recruiting
Plant-based diet study for multiple myeloma patients

This study tests if a plant-based diet can help people with newly diagnosed multiple myeloma who are receiving a standard 4-cycle drug combination (DRVd). Researchers want to see if changing what you eat might improve treatment results.

Basking Ridge, New Jersey
NCT07609706Not yet recruiting· Phase 1
Triple Drug Therapy for Relapsed Multiple Myeloma With Liver Issues

This study tests a combination of three cancer drugs (belantamab mafodotin, bortezomib, and dexamethasone) in people with multiple myeloma who have had prior treatment and moderate liver function problems. The goal is to see if this combination works safely in patients whose cancer has come back or worsened.

NCT05272826Recruiting· Phase 2
New, untreated myeloma study using four medicines

This Phase 2 trial tests a combination of medicines (iberdomide, bortezomib, dexamethasone, and adding isatuximab) for people with newly diagnosed multiple myeloma who cannot have a transplant. The goal is to improve disease control while checking safety in older adults who can take pills and attend frequent visits.

Edmonton, Alberta
NCT07167446Recruiting· Early Phase 1
CBD to prevent nerve damage from oxaliplatin in colorectal cancer

This trial tests if cannabidiol (CBD) can prevent nerve damage (neuropathy) caused by the chemotherapy drug oxaliplatin. If you have colorectal cancer that has spread or cannot be removed by surgery and you are about to start oxaliplatin, you may be able to join.

Philadelphia, Pennsylvania
NCT07333261Recruiting· Phase 1
Study of BMS-986453 for newly diagnosed multiple myeloma

This trial tests a new drug, BMS-986453, for people newly diagnosed with multiple myeloma. It aims to see if the drug is safe and works well for those who cannot or choose not to have a stem cell transplant.

Birmingham, Alabama

Hear when a new Multiple myeloma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.